CK-MB isoforms for early risk stratification of emergency department patients

Area of Science:

• Clinical Biochemistry
• Cardiology
• Emergency Medicine

Background:

• Accurate and timely risk stratification is crucial for Emergency Department (ED) patients presenting with potential myocardial ischemia.
• Current diagnostic methods may have limitations in early and sensitive detection of cardiac events.

Purpose of the Study:

• To evaluate the clinical utility of single-sample CK-MB isoforms measurement for early risk stratification of patients with possible myocardial ischemia in the ED.
• To compare the predictive values of CK-MB isoforms versus standard CK-MB alone for adverse events and myocardial infarction.

Main Methods:

• Prospective study involving 405 patients presenting to urban EDs with suspected myocardial ischemia.
• Collection of clinical and serologic data, including CK-MB isoforms and standard CK-MB levels.
• Recording of adverse events (AEs) and myocardial infarction (MI) within a 14-day outcome period.

Main Results:

• Both CK-MB isoforms and standard CK-MB were predictive of AEs.
• CK-MB isoforms demonstrated significantly higher sensitivity (65.7%) for AEs compared to standard CK-MB (14.9%), identifying more high-risk patients.
• CK-MB isoforms showed superior diagnostic sensitivity and equivalent specificity for predicting MI, supporting their use in early risk assessment.

Conclusions:

• Single-sample CK-MB isoform testing is a valuable tool for early risk stratification in ED patients with suspected myocardial ischemia.
• CK-MB isoforms offer improved sensitivity over standard CK-MB, enabling better identification of patients at high risk for adverse cardiac events.
• The findings support the integration of early CK-MB isoform testing into routine ED practice for enhanced patient management.